Capstan Therapeutics
AcquiredFacts
- Sectors
- Biotechnology, Biopharma, Cell therapy
- Founded
- 2021
- Status
- Acquired
- Stage
- Acquired
Is this your organization? Claim it
Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors
Umoja Biopharma appointed Dr. Marcela Maus and Dr. Athena Countouriotis to its board of directors, expanding leadership with experienced biotech and cell therapy experts.
Shield AI Leads San Diego VC in 2025 with $240M Series F at $5B Valuation; Crystalys Raises $205M Series A
San Diego startups raised more than $100 million across 11 local companies in 2025, led by Shield AI’s $240M Series F at a $5B valuation and Crystalys Therapeutics’ $205M Series A; overall deal count fell 6% year-over-year to 152. Three San Diego companies — Aardvark Therapeutics, Carlsmed and Aptera Motors — went public, and the city ranked seventh nationally for VC funding through Series C.